Previous Article | Next Article ![]()
Infection and Immunity, December 1998, p. 5819-5825, Vol. 66, No. 12
Molecular Genetics Laboratory, International
Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka-1000,
Bangladesh,1 and
Department of
Microbiology and Molecular Genetics, Harvard Medical School,
Boston, Massachusetts 021152
Received 29 June 1998/Returned for modification 19 August
1998/Accepted 5 September 1998
Toxigenic Vibrio cholerae strains are lysogens of
CTX Cholera caused by toxigenic
Vibrio cholerae is a major public health problem in
developing countries. Epidemiological surveillance of cholera and
comparative molecular analysis of strains collected during outbreaks
have demonstrated clonal diversity among epidemic strains and a
continual emergence of new clones of toxigenic V. cholerae
(6-8). The genetic basis of and the mechanisms involved in
the origination of the new epidemic clones have not been adequately explained.
Cholera pathogenesis relies on the synergistic effect of a number of
pathogenic factors produced by toxigenic V. cholerae. Profuse, watery diarrhea, which is characteristic of cholera, is caused
by an enterotoxin, cholera toxin (CT), produced by V. cholerae when it colonizes the small intestine (27).
Molecular analysis has revealed that in addition to genes encoding CT,
all strains capable of causing cholera invariably carry genes for a
colonization factor known as toxin-coregulated pilus (TCP) and a
regulatory protein, ToxR, which coregulates the expression of both CT
and TCP (15, 22, 34). Although the major subunit of TCP is
encoded by the tcpA gene, the formation and function of the
pilus assembly require the products of a number of other genes located
on a large DNA region referred to as the TCP pathogenicity island,
which includes the tcp and acf gene clusters
(19). The ctxAB operon which encodes the A and B
subunits of CT is part of a larger genetic element originally termed
the CTX genetic element. Recent studies have shown that the CTX genetic
element corresponds to the genome of CTX Bacterial strains, plasmids, and phages.
A total of 146 CTX-negative V. cholerae isolates from five different
countries, obtained either from patients or from surface water samples,
were included in the study. Clinical isolates from Bangladesh were
obtained from patients who attended the treatment center of the
International Centre for Diarrhoeal Disease Research, Bangladesh
(ICDDR,B), located in Dhaka. The environmental isolates were from
surface water samples in Dhaka isolated between 1992 and 1996. Other
isolates consisted of four El Tor and three non-O1 strains from
patients in Saudi Arabia (courtesy of M. H. Al-Jefrri, Parasitic
and Infectious Diseases Unit, Department of Preventive Medicine,
Ministry of Health, Riyadh, Kingdom of Saudi Arabia), three El Tor
strains from Estonia and one El Tor strain from Latvia isolated from
seawater (courtesy of Anja Siitonen, Laboratory of Enteric Pathogens,
National Public Health Institute, Helsinki, Finland), and six clinical
El Tor strains (28) from southern India (courtesy of G. B. Nair, National Institute for Cholera and Enteric Diseases, Calcutta,
India). The strains were stored either in lyophilized form or in sealed
deep nutrient agar at room temperature, in the culture collection of
ICDDR,B. Before use, the identities of the cultures were confirmed by
biochemical and serological methods (37), and the presence
or absence of the CTX element was tested with specific DNA probes. The
strains analyzed in this study are described in Table
1. The relevant characteristics of
reference bacterial strains and properties of phages and plasmids used
in this study are listed in Table 2.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Analysis of Clinical and Environmental Strains of
Nontoxigenic Vibrio cholerae for Susceptibility to CTX
:
Molecular Basis for Origination of New Strains with Epidemic
Potential
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References
, a filamentous phage which encodes cholera toxin. The receptor
for CTX
for invading V. cholerae cells is the
toxin-coregulated pilus (TCP), the genes for which reside in a larger
genetic element, the TCP pathogenicity island. We analyzed 146 CTX-negative strains of V. cholerae O1 or non-O1 isolated
from patients or surface waters in five different countries for the
presence of the TCP pathogenicity island, the regulatory gene
toxR, and the CTX
attachment sequence attRS,
as well as for susceptibility of the strains to CTX
, to investigate
the molecular basis for the emergence of new clones of toxigenic
V. cholerae. DNA probe or PCR assays for tcpA,
tcpI, acfB, toxR, and
attRS revealed that 6.85% of the strains, all of which
belonged to the O1 serogroup, carried the TCP pathogenicity island,
toxR, and multiple copies of attRS, whereas the
remaining 93.15% of the strains were negative for TCP but positive for
either one or both or neither of toxR and
attRS. An analysis of the strains for susceptibility to
CTX
, using a genetically marked derivative of the phage CTX-Km
,
showed that all TCP-positive CTX-negative strains and 1 of 136 TCP-negative strains were infected by the phage either in vitro or in
the intestines of infant mice. The phage genome integrated into the
chromosome of infected V. cholerae O1 cells forming stable
lysogens. Comparative analysis of rRNA gene restriction patterns
revealed that the lysogens derived from nontoxigenic progenitors were
either closely related to or distinctly different from previously
described clones of toxigenic V. cholerae. To our
knowledge, this is the first demonstration of lysogenic conversion of
naturally occurring nontoxigenic V. cholerae strains by
CTX
. The results of this study further indicated that strains belonging to the O1 serogroup of V. cholerae are more
likely to possess the TCP pathogenicity island and hence to be infected by CTX
, leading to the origination of potential new epidemic clones.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References
, a lysogenic filamentous
bacteriophage (35). The propagation of the phage has been
studied in recipient laboratory strains of V. cholerae.
CTX
uses TCP as its receptor for invading V. cholerae
cells, in which the phage genome either integrates chromosomally at a
specific attachment site (attRS), forming stable lysogens,
or is maintained extrachromosomally as a replicative form (RF) of the
phage genome (35). We previously studied the induction of
CTX
prophage in naturally occurring strains of toxigenic V. cholerae and demonstrated that wild-type phage particles isolated
from different native strains infected an attenuated CT-negative
V. cholerae strain (10). This indicated that in
the natural habitat, propagation of CTX
may be associated with
horizontal gene transfer, leading to the origination of novel toxigenic
strains of V. cholerae. To further validate this concept, the present study was undertaken to analyze a large number of nontoxigenic V. cholerae strains for the presence of major
virulence-associated genes and for susceptibility of the strains to a
genetically marked derivative of CTX
to investigate the molecular
basis for the origination of novel toxigenic strains with epidemic potential.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References
TABLE 1.
Distribution of major virulence-associated genes among
nontoxigenic Vibrio cholerae O1 and non-O1 strains isolated
from cholera patients or environmental surface water and susceptibility
of the strains to a genetically marked derivative of CTX
TABLE 2.
Characteristics of the V. cholerae reference
strains used in the study
was initially derived from
strain SM44, in which a kanamycin resistance (Kmr)
determinant was introduced by marker exchange disrupting the ctxAB operon (14, 35). CTX-Km
isolated from a
mitomycin C-induced culture of SM44 was used to infect the classical
V. cholerae O1 strain O395. CTX-Km
was prepared for the
present study from a culture of strain O395 carrying an RF of the
phage, O395(pCTX-Km). Aliquots of the culture supernatants were
sterilized by filtration through 0.22-µm-pore-size filters (Millipore
Corp., Bedford, Mass.). To confirm that the filtrate did not contain
any bacterial cells, aliquots of the filtrate were streaked on Luria
agar plates and incubated overnight at 37°C. The filtrate was
titrated for infectious phage particles by incubating aliquots of the
supernatants for 30 min at 30°C with the classical strain RV508,
which constitutively expresses TCP, and then selecting for colonies
resistant to kanamycin.
Probes and hybridization.
The presence of
virulence-associated genes was determined by using specific DNA probes
or PCR assays. The gene probes used in this study to detect the CTX
genetic element were a 0.5-kb EcoRI fragment of pCVD27
(16) containing part of the ctxA gene, an 840-bp
region internal to the zonula occludens toxin gene (zot) amplified by PCR from the recombinant plasmid pBB241 as described previously (9), and a 2.1-kb SphI-XbaI
fragment of pCTX-Km (35) containing the entire
zot and ace genes and part of orfU. The toxR gene probe was a 2.4-kb BamHI fragment
of pVM7 (22). The 18-bp attRS sequence was
identified by using a synthetic oligonucleotide corresponding to the
attRS sequence (25). The rRNA gene probe has been
described by us previously and consisted of a 7.5-kb BamHI
fragment of the Escherichia coli rRNA clone pKK3535 (3, 6). Colony blots or Southern blots were prepared with nylon filters (Hybond; Amersham International plc., Aylesbury, United Kingdom) and processed by standard methods (21, 31). The
polynucleotide probes were labeled by random priming (11)
with a random-primer DNA labeling kit (BRL) and
[
-32P]dCTP (3,000 Ci/mmol; Amersham), and
oligonucleotide probes were labeled by 3' tailing with terminal
deoxynucleotide transferase and [
-32P]dCTP. Southern
blots and colony blots were hybridized with the labeled probes, and
autoradiographs were developed as described by us previously
(6-9).
PCR assays. The presence of the TCP pathogenicity island was determined by PCR assays specific for the tcpA, tcpI, and acfB genes. All oligonucleotides used either as probes or as PCR primers were synthesized commercially by Oswel DNA Service (University of Edinburgh, Edinburgh, United Kingdom), and PCR reagents and kits were purchased from Perkin-Elmer Corp. (Norwalk, Conn.). The presence of tcpA genes specific for the classical and El Tor biotypes was determined by a multiplex PCR assay (18), and the tcpI gene was detected by a PCR assay described by us previously (7). The acfB gene was detected by a PCR assay based on the published sequence of acfB (5) in which two primers with the following sequences were used: 5'GGACCAAGCATTATTATCTCT and 5'AATGATAAACTTACTGATTAA. Thermocycle parameters for the PCR assay consisted of denaturation at 94°C for 2 min, annealing of primers at 50°C for 2 min, and primer extension at 72°C for 3 min. Amplification was performed for 25 cycles, and the size of the amplicon (1.9 kb, which is the expected size) was ascertained by electrophoresis in 1.5% agarose gels. The identities of all PCR products were further verified with specific oligonucleotide probes. The absence of the relevant genes in the PCR-negative strains was further confirmed by colony blot hybridization with the corresponding PCR-generated amplicons from a positive control strain, 569B, as specific probes.
Infection of V. cholerae strains with CTX-Km
.
The susceptibility of V. cholerae strains to the genetically
marked derivative of CTX
was assayed under laboratory conditions and
in the intestines of infant mice by modifications of previously described methods (10, 35). All strains were initially
tested for susceptibility to the phage in vitro. The TCP-positive
strains and a single TCP-negative strain which were found to be
susceptible to the phage in vitro were subjected to further tests both
in vitro and in infant mice. The recipient strains were grown in Luria
broth (LB) at 37°C; the cells were precipitated by centrifugation and
washed in fresh LB. The recipient cells and phage particles were mixed
in LB to make an approximate final concentration of 106
bacterial cells and 106 phage particles per ml. For the in
vitro assay, the mixture was incubated for 16 h at 30°C, and
aliquots of the culture were diluted and plated on Luria agar plates
containing kanamycin (50 µg/ml) to select for kanamycin-resistant
colonies and on plates devoid of kanamycin to determine the total
number of colonies.
Analysis of infected cells.
Representative infected colonies
were grown overnight in LB containing kanamycin (50 µg/ml), and cells
were precipitated by centrifugation. The supernatant fluids of the
cultures were titrated for the presence of CTX-Km
particles by using
strain RV508 as the recipient. Total DNA or plasmids were extracted
from bacterial pellets by standard methods (21) and purified
with microcentrifuge filter units (Ultrafree-Probind; Sigma).
Integration of the phage genome into the chromosomes of the recipient
cells was studied by comparative Southern blot analysis of total DNA
and plasmid preparations from the phage-infected and the corresponding
native strains by using the zot probe.
Analysis of rRNA gene restriction patterns. All the V. cholerae O1 strains included in the study were subjected to comparative analysis of their rRNA gene restriction patterns (ribotype) as described by us previously (6, 7) to study clonal relationships among the strains. Briefly, 5-µg aliquots of total DNA were digested with the appropriate restriction enzyme and electrophoresed in 0.8% agarose gel, and the DNA fragments were blotted onto nylon membranes (Hybond; Amersham). The genomic blots were hybridized with the rRNA gene probe, and autoradiographs were developed as described previously (6-8). rRNA gene restriction patterns produced by the newly formed lysogens derived from nontoxigenic progenitors were compared with previously reported ribotype patterns derived from toxigenic V. cholerae strains isolated from outbreaks of cholera in different countries (4, 6-8, 26).
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Distribution of virulence genes among nontoxigenic V. cholerae.
Most toxigenic V. cholerae strains isolated
from cholera patients simultaneously carry genes for CT, TCP, and ToxR
(7, 8). In order to identify CTX-negative strains which are
possible progenitors or intermediates in the origination of new
toxigenic strains, we studied the distribution of genes encoding TCP
and ToxR and the CTX
attachment sequence
(attRS) among nontoxigenic strains of V. cholerae with either DNA probes or PCR assays. Since the genes
encoding TCP have been suggested to be part of a large genetic element
consisting of clusters of genes, we looked for the simultaneous
presence of the tcpA, tcpI, and acfB
genes to screen for the presence of the TCP pathogenicity island
(17, 19). DNA probe and PCR analysis of a total of 146 CTX-negative strains belonging to the O1 and non-O1 serogroups (Table
1) showed that 6.85% of the strains were positive for the
tcpA, tcpI, and acfB genes and
presumably the entire TCP pathogenicity island in addition to
toxR and attRS; 17.12% were positive
for toxR and attRS but negative for
the TCP pathogenicity island; 60.95% were positive for toxR
but negative for TCP and attRS; and 2.04% were positive for attRS alone but negative for
toxR and TCP. All strains simultaneously positive for TCP,
toxR, and attRS belonged to the O1
serogroup and were of clinical origin, whereas none of the non-O1,
non-O139 strains analyzed in the present study carried the genes for
TCP. In addition, three V. cholerae O1 strains isolated from
seawater in Estonia and Latvia were also negative for TCP. Previous
studies (29, 30, 33) have reported the absence of TCP in
V. cholerae O1 or non-O1 strains which do not produce CT.
The present study demonstrated the existence of TCP-positive, CT-negative V. cholerae strains, although such strains were
less prevalent than TCP-negative strains. Although in the present study we were able to identify 10 isolates of V. cholerae O1 from
Saudi Arabia and India which were TCP positive and CT negative, these results did not reflect the real prevalence of TCP-positive,
CT-negative strains, since in this study we did not analyze a
statistically defined proportion of strains from patients or
environments in different countries. We assume that the real prevalence
of TCP-positive, CT-negative strains should be considerably lower,
taking into consideration previous studies in which no such strain was
isolated from the environment or from patients (13, 29, 33).
Nevertheless, the demonstration of the existence of TCP-positive,
CT-negative strains in the present study is significant for
understanding possible mechanisms involved in the origination of novel
toxigenic strains of V. cholerae. The reason for the
observed low prevalence of CT-negative but TCP-positive strains may be
that these strains do not cause full-blown cholera and hence are not
adequately enriched through interactions with the mammalian host.
Previous studies have shown that CT-positive V. cholerae O1
strains are more enriched in the intestinal environment than the
corresponding CT-negative mutants (1). An alternative
explanation for the low prevalence of CT-negative but TCP-positive
strains may be that such strains are rapidly converted to toxigenic
strains by CTX
either inside the host intestine or in the
environment. The toxR gene was found to be widely
distributed among nontoxigenic V. cholerae strains and was
present in 84.93% of the total strains tested. This was probably
because ToxR is involved in the regulation of a number of other genes
in addition to those encoding TCP and CT (23, 24) and may be
part of a common regulatory mechanism possessed by different serogroups
of V. cholerae. Although toxR and
attRS sequences were shared by both O1 and
non-O1 strains, the possession of genes encoding TCP was confined to
strains of the O1 serogroup. This also agreed with previous studies
(13, 29, 30) in which V. cholerae non-O1,
non-O139 strains have been very rarely found to possess the genes for TCP.
Infection and analysis of recipient strains.
We used a
genetically marked derivative of CTX
designated CTX-Km
(35) to study the susceptibility of the strains because the
Kmr marker allowed us to conveniently detect and analyze
infected cells. Two different methods were used to test the
susceptibility of the nontoxigenic strains to CTX-Km
. Initially, all
the strains were exposed to cell-free phage particles under in vitro
laboratory conditions. Of the 146 nontoxigenic strains exposed to the
phage, 10 strains belonging to the O1 serogroup and 1 non-O1, non-O139 strain were infected by the phage. However, the O1 strains which carried the TCP genes were infected more efficiently than the TCP-negative, non-O1 strain (Fig. 1).
|
infection and the expression of TCP is a prerequisite for
susceptibility to the phage (10, 35). Since TCP is known to
be expressed more efficiently in vivo, we decided to use the infant
mouse model to further test the susceptibility of the 11 strains which
were infected in the initial screening. When the TCP-positive strains were tested in the mouse intestine, the proportion of infected cells
recovered was higher than in the in vitro assay. However, in the case
of the single non-O1 strain which was devoid of TCP, the infant mouse
assay did not produce a higher level of infection than the in vitro
assay (Fig. 1). In the present study, the proportion of infected cells
recovered from both in vitro and in vivo studies possibly included
progeny of infected cells as well as fresh infection of uninfected
cells with phage particles derived from infected cells during the
prolonged incubation period. Nevertheless, for the TCP-positive
strains, the proportion of total cells carrying the phage genome was
found to be significantly higher when the strains were grown inside the
mouse intestine than after an equal length of incubation under
laboratory conditions. Although these results supported previous
reports (10, 35) that recipient strains were more
efficiently infected under conditions conducive to the expression of
TCP, this study also demonstrated that at least one strain which did
not carry the genes for TCP was infected by the phage, albeit at a low
efficiency (Fig. 1). The TCP-negative non-O1, non-O139 strain was
distinctly susceptible to the phage in repeated in vitro assays,
producing a small number of infected colonies, while the rest of the
135 TCP-negative strains were completely resistant to infection by the
phage when assayed under identical conditions. It was not clear what
determined the different phage sensitivities of these TCP-negative
strains. These results indicated that in addition to the TCP-mediated
mechanism, there may be a second mechanism for CTX
infection. In
agreement with this observation, a study in India has reported the
presence of CT-positive but TCP-negative V. cholerae strains
belonging to non-O1 serogroups from both patients and the environment
(13).
In all V. cholerae O1 strains which were infected by
CTX-Km
, the phage genome integrated into the chromosome of the host, forming lysogens (Fig. 2). Hybridization
of genomic DNA digested with BglI or BglII from
infected and corresponding wild-type progenitor strains with the
zot probe produced three bands for BglI and two bands for BglII digests corresponding to the number of
fragments carrying the zot sequence. Since there is a single
BglI site and there are no BglII sites within the
zot gene (2), interpretation of the restriction
patterns confirmed that the phage genome integrated into the chromosome
of the infected V. cholerae cells, and two copies of the
phage genome were present in tandem repeats in the host chromosome
(Fig. 2). Although plasmid preparations from the freshly infected cells
showed the presence of pCTX-Km, the lysogens spontaneously lost the RF
of the phage genome, as confirmed by subsequent plasmid preparations
(data not shown). The integrated form of the phage, however, was
stable, and the lysogens did not lose the prophage when grown or stored
in the absence of kanamycin. In the single non-O1, non-O139 strain,
which was infected by the phage, the phage genome was maintained as the
RF and produced a band corresponding to the linearized pCTX-Km (Fig.
2). This strain produced high titers of infectious phage particles in
the supernatant fluids of the culture (mean, 2.7 × 106 particles/ml), as determined by titration with strain
RV508 as the recipient. Previous studies (20, 35) described
the induction and transmission of CTX
in the intestines of infant
mice based on observed transduction of recipient strains. In the
present study, the presence of at least one non-O1, non-O139 strain in the environment, which was capable of harboring the RF of CTX
and
producing infectious phage particles, indicated that some environmental
non-O1 strains may have a role in supporting the replication and
propagation of CTX
in the environmental habitat. A recent
demonstration of the presence of CT-positive but TCP-negative non-O1,
non-O139 strains in the environment (13) supports this assumption. It is also interesting that a previous study in India reported an increased incidence of toxigenicity among freshwater isolates of V. cholerae non-O1, non-O139 strains during a
cholera outbreak caused by V. cholerae O139 (12).
This emphasizes the importance of further studies to understand the
propagation of CTX
and its role in the ecology of V. cholerae.
|
Analysis of rRNA gene restriction patterns.
In regions where
cholera is endemic, molecular analyses of V. cholerae
strains collected during different epidemics have shown clonal
diversity among strains and a continual emergence of new epidemic
clones (6-8). In these previous studies, clonal diversity was demonstrated based on restriction fragment length polymorphisms in
conserved rRNA genes. We performed rRNA gene restriction pattern analysis (ribotyping) of the new lysogens derived from nontoxigenic progenitors or the native nontoxigenic strains and compared these patterns with those of previous epidemic isolates as well as with published data on the ribotype patterns of toxigenic V. cholerae strains (4, 6-8, 26). Ribotyping was done
with the restriction enzyme BglI, which was previously used
by us and others for comparative analysis of ribotypes. Nontoxigenic
V. cholerae O1 strains analyzed in the present study
revealed four different BglI restriction patterns of their
rRNA genes (Fig. 3). The four different
patterns corresponded to strains collected from four
countries
Estonia, Latvia, India, and Saudi Arabia
whereas all the O1
strains collected from each of these countries were clonal and produced
identical restriction patterns (Fig. 3). Strains from Saudi Arabia and
from India were positive for the TCP pathogenicity island and were lysogenized by the CTX-Km
phage, whereas those from Estonia and Latvia were negative for TCP and were resistant to the phage. The rRNA
gene restriction patterns of the V. cholerae O1 strains from
Estonia, Latvia, and Saudi Arabia were distinctly different from the
restriction patterns of V. cholerae previously reported by
us and other investigators who analyzed a large number of toxigenic V. cholerae strains isolated in different countries (4,
6-8, 26). This data provided evidence that the observed clonal
diversity among epidemic strains of V. cholerae may have
arisen, at least partly, due to the emergence of new toxigenic strains
from nontoxigenic V. cholerae which are possibly undergoing
a continuous genetic reassortment. This study also suggested that in an
area where cholera is endemic, clinical and environmental surveillance
for the presence of nontoxigenic V. cholerae carrying the
genetic determinants for TCP and ToxR and the
attRS sequence may be a means for predicting the
origination of new toxigenic V. cholerae strains. The
ribotype pattern of the new CTX-Km
lysogens derived from the
nontoxigenic southern India strains in this study, however, was very
similar to that of a clone of toxigenic V. cholerae strains isolated from cholera outbreaks in 1987 in Guinea-Bissau
(4), situated along the West African coast. This suggested
that the lysogenic conversion by CTX
demonstrated in the present
study under laboratory conditions may indeed have been occurring
efficiently in the ecological habitat.
|
Molecular basis for the emergence of potential epidemic
strains.
Previous analysis of V. cholerae strains
isolated from cholera epidemics has shown that in addition to genes
encoding CT, these strains invariably possessed genes for the pilus
colonization factor, TCP, and the regulatory gene toxR
(7, 8). Hence, nontoxigenic strains capable of causing
cholera outbreaks following conversion by CTX
should carry genes for
TCP and ToxR, not only because TCP facilitates colonization inside the
host intestine but also because TCP is the phage receptor in recipient
cells. The presence of attRS as well as
toxR in 25 of 132 non-O1 strains (18.93%) in the present
study suggested that such strains were probably capable of integrating
the CTX
genome and support the expression of the ctxAB
operon, although in most cases CTX
would not infect such strains due
to lack of the receptor, TCP. Hence, the presence of the TCP
pathogenicity island remains the limiting factor for infection and
conversion of nontoxigenic environmental strains by CTX
. The
proposed TCP pathogenicity island shares several characteristics with
those of other species of pathogenic bacteria. These include the
presence of groups of virulence genes, a regulator of virulence genes,
a transposase gene, specific (att-like) attachment sites
flanking each end of the island, and an integrase with homology to a
phage integrase gene (17, 19). The structure of the
pathogenicity island is suggestive of horizontal transfer of the gene
clusters as a possible mechanism for the origination of new pathogenic
clones of V. cholerae. In the present study, all strains
positive for tcpA, which encodes the major subunit of TCP,
were simultaneously positive for tcpI and acfB
genes, providing further evidence in favor of the pathogenicity island concept for the transfer of genes encoding TCP.
, as shown
in the present study, it is highly improbable that the CT-negative, TCP-positive strains emerged from toxigenic strains by excision of the
entire CTX element (the CTX
genome). Lazar and Waldor (20) have recently proposed that the CTX
genome is
maintained in TCP-positive V. cholerae cells by a continuous
reinfection of cells by resulting phage particles. The demonstration of
the existence of V. cholerae O1 strains which were negative
for both TCP and CT, and strains which were positive for TCP but
negative for CT, was more consistent with the concept of origination of the later group of strains by acquisition of the TCP pathogenicity island by TCP-negative, CT-negative progenitors. However, the transmission of the TCP pathogenicity island to a recipient strain under laboratory conditions is yet to be demonstrated. The recent discovery of CTX
has provided an impetus to investigate the role of
CTX
in the emergence of new toxigenic strains. In the present study,
we have demonstrated for the first time lysogenic conversion of
naturally occurring nontoxigenic V. cholerae strains by
CTX
. Since TCP is the receptor for CTX
infection, the sequence of events that leads to the origination of new toxigenic strains should
include acquisition of TCP, followed by infection and lysogenic conversion with CTX
. The different combinations of
virulence-associated genes carried by different groups of V. cholerae strains analyzed in the present study and the
demonstration of lysogenic conversion support this assumption.
Epidemic outbreaks of cholera are known to be caused by V. cholerae belonging to the O1 serogroup or the recently emerged O139 serogroup, which possibly evolved from the O1 El Tor strains by
serotype-specific genetic changes (32, 36). In the present study, all the nontoxigenic strains which carried the genes for TCP and
were subsequently converted by the CTX phage also belonged to the O1
serogroup. That none of the 132 non-O1, non-O139 strains analyzed
carried the genes for TCP suggested that possession of the TCP
pathogenicity island may be characteristic of the O1 vibrios. Since the
TCP pathogenicity island is the initial genetic element required for
the origination of epidemic strains, this explains why V. cholerae O1 and O139 (possibly derived from a parental O1 strain)
are the only serogroups capable of causing epidemic cholera. It is not
clear, however, what determines the efficient acquisition of the TCP
pathogenicity island by the O1 serogroup of V. cholerae.
In the present study, most of the nontoxigenic V. cholerae
O1 strains expressed TCP and hence ToxR, as evidenced by the fact that
the strains were efficiently infected by CTX-Km
. It was not possible
to study the expression of CT in the corresponding lysogens of
CTX-Km
, since the ctxAB operon in the phage had been disrupted by the insertion of the kanamycin resistance gene. However, the native strains were isolated from outbreaks of diarrhea, and since
these strains carried functional genes for TCP and ToxR, it is
understandable that such strains should produce CT when infected with
the wild-type CTX
and thus emerge as toxigenic strains capable of
expressing all three major virulence determinants
ToxR, TCP, and
CT
normally found in epidemic V. cholerae isolates. The present study thus demonstrated the genetic basis for the origination of new V. cholerae strains with epidemic potential from
nontoxigenic strains. However, the predominance of the new strains over
existing epidemic strains may involve environmental as well as host
factors associated with the natural selection and enrichment of
particular toxigenic clones. Further studies are required to understand
the interactions of these factors in the evolution of V. cholerae strains with epidemic potential.
| |
ACKNOWLEDGMENTS |
|---|
This research was funded by the U.S. Agency for International Development (USAID) under grant HRN-5986-A-00-6005-00 with the ICDDR,B. The ICDDR,B is supported by countries and agencies which share its concern for the health problems of developing countries.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Molecular Genetics Laboratory, Laboratory Sciences Division, ICDDR,B, GPO Box 128, Dhaka-1000, Bangladesh. Phone: 880 2 871751 to 880 2 871760. Fax: 880 2 872529 and 880 2 883116. E-mail: faruque{at}icddrb.org.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Baselski, V. S.,
R. A. Medina, and C. D. Parker.
1979.
In vivo and in vitro characterization of virulence-deficient mutants of Vibrio cholerae.
Infect. Immun.
24:111-116 |
| 2. |
Baudry, B.,
A. Fasano,
J. Ketley, and J. B. Kaper.
1992.
Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae.
Infect. Immun.
60:428-434 |
| 3. | Brosius, J., A. Ullrich, M. A. Raker, A. Gray, T. J. Dull, R. R. Gutell, and H. F. Noller. 1981. Construction and fine mapping of recombinant plasmids containing the rRNB ribosomal RNA operon of E. coli. Plasmid 6:112-118[Medline]. |
| 4. | Dalsgaard, A., H. F. Mortensen, K. Mølbak, F. Dias, O. Serichantalergs, and P. Echeverria. 1996. Molecular characterization of Vibrio cholerae O1 strains isolated during cholera outbreaks in Guinea-Bissau. J. Clin. Microbiol. 34:1189-1192[Abstract]. |
| 5. |
Everiss, K. D.,
K. J. Hughes,
M. E. Kovach, and K. M. Peterson.
1994.
The Vibrio cholerae acfB colonization determinant encodes an inner membrane protein that is related to a family of signal-transducing proteins.
Infect. Immun.
62:3289-3298 |
| 6. | Faruque, S. M., S. K. Roy, A. R. M. A. Alim, A. K. Siddique, and M. J. Albert. 1995. Molecular epidemiology of toxigenic Vibrio cholerae in Bangladesh studied by numerical analysis of rRNA gene restriction patterns. J. Clin. Microbiol. 33:2833-2838[Abstract]. |
| 7. | Faruque, S. M., K. M. Ahmed, A. R. M. A. Alim, F. Qadri, A. K. Siddique, and M. J. Albert. 1997. Emergence of a new clone of toxigenic Vibrio cholerae O1 biotype El Tor displacing V. cholerae O139 Bengal in Bangladesh. J. Clin. Microbiol. 35:624-630[Abstract]. |
| 8. | Faruque, S. M., K. M. Ahmed, A. K. Siddique, K. Zaman, A. R. M. A. Alim, and M. J. Albert. 1997. Molecular analysis of toxigenic Vibrio cholerae O139 Bengal strains isolated in Bangladesh between 1993 and 1996: evidence for emergence of a new clone of the Bengal vibrios. J. Clin. Microbiol. 35:2299-2306[Abstract]. |
| 9. | Faruque, S. M., L. Comstock, J. B. Kaper, and M. J. Albert. 1994. Distribution of zonula occludens toxin (zot) gene among clinical isolates of Vibrio cholerae O1 from Bangladesh and Africa. J. Diarrhoeal Dis. Res. 12:222-224[Medline]. |
| 10. |
Faruque, S.,
M. Asadulghani,
A. R. M. A. Alim,
M. J. Albert,
K. M. N. Islam, and J. J. Mekalanos.
1998.
Induction of the lysogenic phage encoding cholera toxin in naturally occurring strains of toxigenic Vibrio cholerae O1 and O139.
Infect. Immun.
66:3752-3757 |
| 11. | Feinberg, A., and B. Volgelstein. 1984. A technique for radio labelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137:266-267[Medline]. |
| 12. | Ghosh, A. R., H. Koley, D. De, S. Garg, M. K. Bhattacharya, S. K. Bhattacharya, B. Manna, G. B. Nair, T. Shimada, T. Takeda, and Y. Takeda. 1994. Incidence and toxigenicity of Vibrio cholerae in a freshwater lake during the epidemic of cholera caused by serogroup O139 Bengal in Calcutta, India. FEMS Microbiol. Ecol. 14:285-291. |
| 13. | Ghosh, C., R. K. Nandi, S. K. Dasgupta, G. B. Nair, R. H. Hall, and A. C. Ghose. 1997. A search for cholera toxin (CT), toxin coregulated pilus (TCP), the regulatory element ToxR and other virulence factors in non-O1/non-O139 Vibrio cholerae. Microb. Pathog. 22:199-208[Medline]. |
| 14. |
Goldberg, I., and J. J. Mekalanos.
1986.
Effect of a recA mutation on cholera toxin gene amplification and deletion events.
J. Bacteriol.
165:723-731 |
| 15. |
Herrington, D. A.,
R. H. Hall,
G. Losonsky,
J. J. Mekalanos,
R. K. Taylor, and M. M. Levine.
1988.
Toxin, toxin-coregulated pili and ToxR regulon are essential for Vibrio cholerae pathogenesis in humans.
J. Exp. Med.
168:1487-1492 |
| 16. | Kaper, J. B., J. G. Morris, Jr., and M. Nishibuchi. 1988. DNA probes for pathogenic Vibrio species, p. 65-77. In F. C. Tenover (ed.), DNA probes for infectious disease. CRC Press, Inc., Boca Raton, Fla. |
| 17. |
Karaolis, D. K.,
J. A. Johnson,
C. C. Bailey,
E. C. Boedeker,
J. B. Kaper, and P. R. Reeves.
1998.
A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains.
Proc. Natl. Acad. Sci. USA
95:3134-3139 |
| 18. | Keasler, S. P., and R. H. Hall. 1993. Detection and biotyping Vibrio cholerae O1 with multiplex polymerase chain reaction. Lancet 341:1661[Medline]. |
| 19. |
Kovach, M. E.,
M. D. Shaffer, and K. M. Peterson.
1996.
A putative integrase gene defines the distal end of a large cluster of ToxR-regulated colonization genes in Vibrio cholerae.
Microbiology
142:2165-2174 |
| 20. |
Lazar, S., and M. K. Waldor.
1998.
ToxR-independent expression of cholera toxin from the replicative form of CTX .
Infect. Immun.
66:394-397 |
| 21. | Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 22. |
Miller, V. L., and J. J. Mekalanos.
1984.
Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR.
Proc. Natl. Acad. Sci. USA
81:3471-3475 |
| 23. |
Miller, V. L., and J. J. Mekalanos.
1988.
A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR.
J. Bacteriol.
170:2575-2583 |
| 24. |
Parsot, C., and J. J. Mekalanos.
1991.
Expression of the Vibrio cholerae gene encoding aldehyde dehydrogenase is under control of ToxR, the cholera toxin transcriptional activator.
J. Bacteriol.
173:2842-2851 |
| 25. |
Pearson, G. D. N.,
A. Woods,
S. L. Chiang, and J. J. Mekalanos.
1993.
CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor.
Proc. Natl. Acad. Sci. USA
90:3750-3754 |
| 26. |
Popovic, T.,
C. Bopp,
Ø. Olsvic, and K. Wachsmuth.
1993.
Epidemiological application of a standardized ribotype scheme for Vibrio cholerae O1.
J. Clin. Microbiol.
31:2474-2482 |
| 27. | Rabbani, G. H., and W. B. Greenough. 1990. Cholera, p. 233-253. In E. Lebenthal, and M. Duffy (ed.), Text book of secretory diarrhea. Raven Press, New York, N.Y. |
| 28. | Saha, P. K., H. Koley, A. K. Mukhopadhyay, S. K. Bhattacharya, G. B. Nair, B. S. Ramakrishnan, S. Krishnan, T. Takeda, and Y. Takeda. 1996. Nontoxigenic Vibrio cholerae O1 serotype Inaba biotype El Tor associated with a cluster of cases of cholera in southern India. J. Clin. Microbiol. 34:1114-1117[Abstract]. |
| 29. | Said, B., H. R. Smith, S. M. Scotland, and B. Rowe. 1995. Detection and differentiation of the gene for toxin co-regulated pili (tcpA) in Vibrio cholerae non-O1 using the polymerase chain reaction. FEMS Microbiol. Lett. 125:205-210[Medline]. |
| 30. |
Sharma, C.,
M. Thungapathra,
A. Ghosh,
A. K. Mukhopadhyay,
A. Basu,
R. Mitra,
I. Basu,
S. K. Bhattacharya,
T. Shimada,
T. Ramamurthy,
T. Takeda,
S. Yamasaki,
Y. Takeda, and G. B. Nair.
1998.
Molecular analysis of non-O1, non-O139 Vibrio cholerae associated with an unusual upsurge in the incidence of cholera-like disease in Calcutta, India.
J. Clin. Microbiol.
36:756-763 |
| 31. | Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517[Medline]. |
| 32. |
Stroeher, U. H.,
K. E. Jedani,
B. K. Dredge,
R. Morona,
M. H. Brown,
L. E. Karageorgos,
M. J. Albert, and P. A. Manning.
1995.
Genetic rearrangements in the rfb regions of Vibrio cholerae O1 and O139.
Proc. Natl. Acad. Sci. USA
92:10374-10378 |
| 33. | Taylor, R., C. Shaw, K. Peterson, P. Spears, and J. Mekalanos. 1988. Safe, live Vibrio cholerae vaccines? Vaccine 6:151-154[Medline]. |
| 34. |
Taylor, R. K.,
V. L. Miller,
D. B. Furlong, and J. J. Mekalanos.
1987.
Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.
Proc. Natl. Acad. Sci. USA
84:2833-2837 |
| 35. | Waldor, M. K., and J. J. Mekalanos. 1996. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272:1910-1914[Abstract]. |
| 36. |
Waldor, M. K., and J. J. Mekalanos.
1994.
ToxR regulates virulent gene expression in non-O1 strains of Vibrio cholerae that cause epidemic cholera.
Infect. Immun.
62:72-78 |
| 37. | World Health Organization. 1974. World Health Organization guidelines for the laboratory diagnosis of cholera. Bacterial Disease Unit, World Health Organization, Geneva, Switzerland. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»